Update under Regulation 30 read with Para A Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) REgulations, 2015
MEDPLUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Optival Health Solutions Private Limited, a subsidiary of Medplus Health Services, has received three suspension orders for drug licenses from Drug Control Administration authorities. Three pharmacy stores have been affected: one in Telangana (3-day suspension, Rs 1.35 lakhs potential revenue loss) and two in Karnataka (2-day suspension with Rs 1.49 lakhs loss, and 1-day suspension with Rs 0.65 lakhs loss). The suspensions are for stores located in Maruthi Nagar Kothapet (Telangana), Channappa Layout Nelamangala (Karnataka), and Binny Mill Road Ganganagar (Karnataka). The violations relate to Rule 65 of the Drugs and Cosmetics Act, 1940 and Rules 1945. Orders were received on May 27, 2026. Total potential revenue loss across all three stores is approximately Rs 3.49 lakhs.
Short-term operational disruption at three pharmacy stores with minor quantified revenue impact of Rs 3.49 lakhs. The suspensions are brief (1-3 days), suggesting compliance issues may be resolvable. However, it highlights regulatory compliance risk for the pharmacy retail business.